I am bullish on NBIX, but I don't believe that there is anything eventful coming up in the next couple of months. Elagolix for Fibroids Phase II will close out late in 2012, so we won't see any data until 2013. I think that's the closest data point. So, it just might stupidly go up or down based on beating or missing the -$.03 quarterly forecast. At least, we'll get a full status report of the pipeline which should give us reconfirmation of a $14 price target.
So, I'm just hanging on for the ride. Maybe I'll be surprised.